Holen Sie sich die Stockscreener-App
8.10
1.89%
0.15
Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
40.64%
0.3057
|
0.515 | 0.4354 | 0.4905 | 0.7896 |
Operating Expenses
|
41.46%
2.1487
|
3.6707 | 3.1427 | 2.7844 | 3.3509 |
| Interest Income/Expense |
261.97%
1.2481
|
0.3448 | 0.00765 | - | 0.0015 |
| Benefits Costs and Expenses |
14.86%
3.4223
|
4.0194 | 3.1262 | 2.7298 | 2.9814 |
| Costs And Expenses |
14.86%
3.4223
|
4.0194 | 3.1262 | 2.7298 | 2.9814 |
| Operating Income/Loss |
41.60%
-1.843
|
-3.1557 | -2.7073 | -2.294 | -2.5612 |
| Nonoperating Income/Loss |
265.27%
-1.2736
|
-0.3487 | 0.0165 | 0.0547 | 0.3694 |
| Income/Loss From Continuing Operations Before Tax |
11.07%
-3.1166
|
-3.5044 | -2.6908 | -2.2393 | -2.1918 |
| Income/Loss From Continuing Operations After Tax |
11.07%
-3.1166
|
-3.5044 | -2.6908 | -2.2393 | -2.1918 |
|
Net Income/Loss
|
11.07%
-3.1166
|
-3.5044 | -2.6908 | -2.2393 | -2.1918 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
92.33%
-0.000074
|
-0.000965 | -0.00124 | -0.00706 | -0.00394 |
| Basic Average Shares |
4,703%
5.6945
|
0.1186 | 3.0859 | 2.2741 | 1.0542 |
| Diluted Average Shares |
4,703%
5.6945
|
0.1186 | 3.0859 | 2.2741 | -0.6066 |
| Basic Earnings Per Share |
59.85%
-0.55
|
-1.37 | -0.87 | -0.98 | -2.08 |
| Diluted Earnings Per Share |
59.85%
-0.55
|
-1.37 | -0.87 | -0.98 | -1.68 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):